← Back to guidelines
Cardiology32 papers

Tryptophan malabsorption syndrome

Last edited: 4/23/2026

Overview

Tryptophan malabsorption syndrome involves impaired absorption of tryptophan, an essential amino acid crucial for neuronal function, immunity, and gut homeostasis. This condition can disrupt the metabolism pathways leading to serotonin, melatonin, and niacin, potentially affecting neurologic, psychiatric, and immune functions 1.

Diagnosis

  • Clinical presentation may include symptoms related to tryptophan deficiency such as mood disturbances, sleep disorders, and immune dysfunction.
  • Laboratory tests often reveal low serum tryptophan levels.
  • Assessment of kynurenine pathway metabolites can provide additional diagnostic insight into metabolic imbalances 1.
  • Management

  • Supplementation with tryptophan under medical supervision to correct deficiencies.
  • Dietary modifications to enhance tryptophan absorption and reduce competition from other amino acids.
  • Adjunctive therapies targeting specific symptoms, such as selective serotonin reuptake inhibitors (SSRIs) for mood disorders, based on clinical judgment 1.
  • Special Populations

  • Pregnancy: Limited evidence; monitoring and supplementation should be individualized with close clinical follow-up 1.
  • Pediatrics: Growth and development monitoring essential; tailored nutritional support recommended 1.
  • Elderly: Increased vigilance for immune and neurologic symptoms; consider multifactorial management approaches 1.
  • Comorbidities: Tailored management considering interactions with existing conditions like inflammatory bowel disease or cardiovascular disease 1.
  • Key Recommendations

  • Initiate tryptophan supplementation for confirmed deficiencies, guided by serum levels and clinical response (Evidence: Moderate 1).
  • Implement dietary counseling to optimize tryptophan intake and absorption (Evidence: Expert opinion 1).
  • Monitor patients closely for symptom resolution and potential side effects, especially in vulnerable populations like pregnant women and the elderly (Evidence: Moderate 1).
  • References

    1 Comai S, Bertazzo A, Brughera M, Crotti S. Tryptophan in health and disease. Advances in clinical chemistry 2020. link

    Original source

    1. [1]
      Tryptophan in health and disease.Comai S, Bertazzo A, Brughera M, Crotti S Advances in clinical chemistry (2020)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG